arrow
返回
D

Daniel A. Pollyea

University of Colorado School of Medicine

70H指数
552论文数
2.5W被引数
收录论文 115
发表时间
A Phase 1/1b Study of the All-Oral Regimen CC-486 and Venetoclax in Acute Myeloid Leukemia一项CC-486和Venetoclax口服方案在急性髓系白血病中的I/1b期研究
err2026-07-28
err0
errOAAI
errMaria L. Amaya; Diana Abbott; Christine McMahon; Marc Schwartz; Jonathan Gutman; Andrew Kent; Mathew Angelos; Connor Sohalski; Ayele Belachew; Jessica Dell-Martin; Katelyn Anttila; Brett Stevens; Angelo D’Alessandro; William Showers; Austin E. Gillen; Craig T. Jordan; Daniel A. Pollyea
err分享
err收藏
Tolerability and Outcomes With Serial Cycles of 28 Days of Venetoclax in Newly Diagnosed Patients With Acute Myeloid Leukemia新诊断急性髓系白血病患者的耐受性与结局:接受连续28天周期性Venetoclax治疗的研究
err2026-02-13
err0
PREAI
errMichael K. Jones; Jesse Sanchez; Megan Connor; Katherine Julian; Rebecca Rezac; Kelsey Marciano; Jennifer Tobin; Grace Bosma; Diana Abbott; Katelyn Anttila; Connor Sohalski; Ayele Belachew; Christine McMahon; Andrew Kent; Maria Amaya; Mathew G. Angelos; Marc Schwartz; Jonathan A. Gutman; Daniel A. Pollyea
err分享
err收藏
The STAT3-VDAC1 axis modulates mitochondrial function and plays a critical role in the survival of acute myeloid leukemia cellsSTAT3-VDAC1轴调控线粒体功能并在急性髓系白血病细胞存活中发挥关键作用
err2026-02-01
err5
errOAAI
errGil, Kellen B.; Borg, Jamie; Pereira, Rosana Moreira; Inguva-Sheth, Anagha; Araujo, Geovana; Rahkola, Jeremy; Showers, William; Grier, Abby; D'Alessandro, Angelo; Smith, Clayton; Mcmahon, Christine; Pollyea, Daniel A.; Gillen, Austin E.; Amaya, Maria L.
err分享
err收藏
Evolving Treatment Strategies for Acute Myeloid Leukemia
err2025-11-01
err0
PREAI
errAltman, Jessica K.; Pollyea, Daniel A.; Daver, Naval G.
err分享
err收藏
Omacetaxine and azacitidine for untreated patients with myelodysplastic syndromes and excess blasts: a phase I/II clinical trial奥马曲拉和氮杂胞苷用于初治的伴有过多 blasts 的骨髓增生异常综合征患者的 I/II 期临床试验
err2025-10-10
err0
errOAAI
errDaniel A. Pollyea; Brett M. Stevens; Diana Abbott; Maria Amaya; Jonathan A. Gutman; Andrew Kent; Christine McMahon; Marc Schwartz; Clayton Smith; Jessie Dell-Martin; Connor Sohalski; Alexandra Ellis; Mary Haag; Jeffrey Schowinsky; Zenggang Pan; Sweta B. Patel; Monica Ransom; Austin Gillen; Craig T. Jordan; Eric M. Pietras
err分享
err收藏
Plasma lipid levels predict chemotherapy response and survival in acute myeloid leukemia血浆脂质水平预测急性髓系白血病的化疗反应和生存期
errBlood
IF23.1
err2025-08-28
err0
errOAAI
errCristiana O’Brien; Nirvana Nursimulu; Anit Tyagi; Rachel Culp-Hill; Andrea Arruda; Tracy Murphy; Mark D. Minden; Andrew Kent; Brett Stevens; Daniel A. Pollyea; Kristin Hope; Sushant Kumar; Julie A. Reisz; Angelo D'Alessandro; Courtney L. Jones
err分享
err收藏
Hypomethylating Agent and Venetoclax Combination Is a Safe and Effective Alternative to Intensive Chemotherapy in Older (≥ 70 Years) Patients With Newly Diagnosed Favorable Risk Acute Myeloid Leukemia去甲基化药物与Venetoclax联合方案是老年(≥70岁)新诊断低危急性髓系白血病患者接受强化化疗的安全有效替代方案。
err2025-08-07
err0
PREAI
errSomedeb Ball; Akriti G. Jain; Najla Al Ali; Luis E. Aguirre; Jan Philipp Bewersdorf; Andrew Kent; Ameera Rose; Alexander Hayden; Alexa Siddon; Jill Lykon; Ellen Madarang; David M. Swoboda; Eric Padron; Kendra Sweet; David A. Sallman; Jeffrey Lancet; Hetty E. Carraway; Justin Watts; Amer Zeidan; Daniel A. Pollyea; Rami S. Komrokji
err分享
err收藏
Refined ELN 2024 risk stratification improves survival prognostication following venetoclax-based therapy in AML优化后的ELN 2024风险分层改善了接受venetoclax为基础治疗后的AML患者的生存预测。
errBLOOD
IF23.1
err2024-12-26
err1
PREAI
errLachowiez, Curtis A.; Ravikumar, Vishvaas I.; Othman, Jad; O'Nions, Jenny; Peters, Daniel T.; Mcmahon, Christine; Swords, Ronan; Cook, Rachel; Saultz, Jennifer N.; Tyner, Jeffrey W.; Dillon, Richard; Zeidner, Joshua F.; Pollyea, Daniel A.
err分享
err收藏
PTPN11 Mutations Are Associated with Shorter Survival in Patients with Acute Myeloid Leukemia Treated with Hypomethylating Agents and VenetoclaxPTPN11基因突变与接受表观遗传药物(包括低甲基化剂和Venetoclax)治疗的急性髓系白血病患者生存期缩短相关。
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errRavikumar, Vishvaas, I; Leonard, Jessica T.; Newell, Laura F.; Gandhi, Arpita; Meyers, Gabrielle; Hayes-Lattin, Brandon; Maziarz, Richard T.; Cook, Rachel J.; Traer, Elie; Swords, Ronan T.; Saultz, Jennifer N.; Tyner, Jeffrey W.; Heiblig, Mael; Zeidner, Joshua F.; Pollyea, Daniel A.; Lachowiez, Curtis A.
err分享
err收藏
Omacetaxine and Azacitidine for Newly Diagnosed Patients with Myelodysplastic Syndromes and Excess Blasts奥马扎克汀和阿扎胞苷用于新诊断的伴有过多原始细胞的骨髓增生异常综合征患者
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errPollyea, Daniel A.; Stevens, Brett M.; Abbott, Diana; Amaya, Maria L.; Gutman, Jonathan; Kent, Andrew; Mcmahon, Christine M.; Schwartz, Marc; Smith, Clayton; Dell-Martin, Jessica; Sohalski, Connor; Ellis, Alexandra; Haag, Mary; Schowinsky, Jeffrey; Pan, Zenggang; Patel, Sweta B.; Ransom, Monica; Gillen, Austin E.; Pietras, Eric M.; Jordan, Craig
err分享
err收藏
Immunophenotypic Markers CD7 and CD56 Improve Risk Stratification of Frontline Hypomethylating Agents plus Venetoclax in Newly Diagnosed AML免疫表型标志物CD7和CD56可改善一线低甲基化药物联合Venetoclax在初诊AML中的风险分层
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errLachowiez, Curtis A.; Peters, Daniel; Fang, Jacob; Kaempf, Andy; Leonard, Jessica T.; Newell, Laura F.; Gandhi, Arpita; Meyers, Gabrielle; Hayes-Lattin, Brandon; Maziarz, Richard T.; Cook, Rachel J.; Traer, Elie; Swords, Ronan T.; Tyner, Jeffrey W.; Zeidner, Joshua F.; Pollyea, Daniel A.; Saultz, Jennifer N.
err分享
err收藏
Treatment-Related and De Novo Ccus Have Similar Molecular Features and Risk of Progression to Myeloid Malignancies治疗相关性和新发性克隆性造血细胞克隆具有相似的分子特征和进展为髓系恶性肿瘤的风险。
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errSantos, Jennifer; Abbott, Diana; Bosma, Grace; Kent, Andrew; Schwartz, Marc; Mcmahon, Christine M.; Gutman, Jonathan; Pollyea, Daniel A.; Amaya, Maria L.
err分享
err收藏
Deep Learning Predicts Response to Venetoclax and Azacitidine in Patients with Newly Diagnosed Acute Myeloid Leukemia Solely Based on Bone Marrow Smear Image Data深度学习基于骨髓涂片图像数据预测新诊断急性髓系白血病患者的维奈克拉和阿扎胞苷治疗反应
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errEckardt, Jan-Niklas; Srivastava, Ishan; Xu, Yeqiao; Gil, Kellen B.; Osypuk, Andrea A.; Pan, Zenggang; Schneider, Martin M. K.; Schulze, Freya; Wendt, Karsten; Winter, Susann; Bornhaeuser, Martin; Pollyea, Daniel A.; Middeke, Jan Moritz
err分享
err收藏
Outcomes of Haplo-Cord Versus Dual Cord Transplants: A Single-Center Retrospective Analysis
err2024-08-01
err0
PREAI
errKent, Andrew; Gil, Kellen B.; Jones, Michael K.; Linden, Brooke; Purev, Enkhee; Haverkos, Bradley; Schwartz, Marc; McMahon, Christine; Amaya, Maria; Smith, Clayton A.; Bosma, Grace; Abbott, Diana; Rabinovitch, Rachel; Milgrom, Sarah A.; Pollyea, Daniel A.; Gutman, Jonathan A.
err分享
err收藏
Frontline therapy of acute myeloid leukemia with lower intensity regimens: Where are we now and where can we go?
err2024-07-17
err0
PREAI
errMarvin-Peek, Jennifer; Gilbert, Jason S.; Pollyea, Daniel A.; DiNardo, Courtney D.
err分享
err收藏
Targeting Acute Myeloid Leukemia Stem Cells through Perturbation of Mitochondrial Calcium
err2024-05-23
err1
errOAAI
errSheth, Anagha Inguva; Althoff, Mark J.; Tolison, Hunter; Engel, Krysta; Amaya, Maria L.; Krug, Anna E.; Young, Tracy N.; Minhajuddin, Mohammad; Pei, Shanshan; Patel, Sweta B.; Winters, Amanda; Miller, Regan; Shelton, Ian T.; St-Germain, Jonathan; Ling, Tianyi; Jones, Courtney L.; Raught, Brian; Gillen, Austin E.; Ransom, Monica; Staggs, Sarah; Smith, Clayton A.; Pollyea, Daniel A.; Stevens, Brett M.; Jordan, Craig T.
err分享
err收藏